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We thank Dr. Poncelet for his comments on our paper. 1 The patients were operated on between July 1989 and December 2000, with increasing numbers of patients in more recent years. The median follow-up was 2.4 years (range 0.1 to 9.6).
The Kaplan-Meier analysis was indeed 2-fold, with recurrence of mitral regurgitation (MR) Ͼ2ϩ and Ͼ1ϩ, respectively as event. The rate of recurrence of MR Ͼ1ϩ was 8.3% per year, and 3.7% when Ͼ2ϩ was considered, and with all patients operated on for degenerative MR included. The rate of reoperation was Ͻ4% in 5 years, which is comparable to other published series.
We have looked for predictors of recurrence of MR Ͼ2ϩ, because we considered this as clinically significant. We also found that bileaflet disease patients have a higher risk of recurrence and reported it in the Results section. In the predictor "surgical risk factors," we have grouped surgical techniques that apparently influence the success rate of the repair. Because the surgeon has no impact on the preoperative pathology, bileaflet disease was not included in these surgical risk factors. The year of surgery is correlated with the techniques used. Therefore, we did not look at the year of surgery but to the surgical techniques themselves as predictors for recurrence. Also in our analysis, anterior leaflet repair with artificial chordae or chordal transfer is no predictor for recurrence, and thus it was not included in the surgical risk factors.
We do not want to discourage surgeons from performing a mitral valve repair for severe MR, even in asymptomatic patients. But the recurrence rate of MR, even when not necessarily leading to reoperation in the first decade, should be considered and discussed with the patient. However, when operations in asymptomatic patients with moderate MR are proposed, a word of caution is appropriate, because the study population of Ling et al 2 from the Mayo Clinics included patients with flail leaflets and ensuing, mostly severe MR. Generalizing the conclusions of this study to patients with moderate MR and to patients with other degenerative pathologies of the mitral valve seems inappropriate. Early surgery in the definition of Ling et al 2 does not mean surgery for moderate MR of all etiologies.
